Galdu-irabazien kontua
SCHNEIDER NATIONAL, INC.
SNDR
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
5,674.30 | 5,290.50 | 5,498.90 | 6,604.40 | 5,608.70 | 4,552.80 | 4,747.00 | 4,977.00 | 4,383.60 |
|
Diru-sarreren kostua
|
- | - | - | - | - | - | 1,996.40 | 1,965.90 | - |
|
Irabazi gordina
|
5,674.30 | 5,290.50 | 5,498.90 | 6,604.40 | 5,608.70 | 4,552.80 | 2,750.60 | 3,011.10 | 4,383.60 |
|
Ustiapen-gastuak
|
725.30 | 636.50 | 576.00 | 534.00 | 462.40 | 533.00 | 0.00 | 0.00 | 0.00 |
|
Ikerketa eta garapena
|
- | - | - | - | - | - | - | - | - |
|
Salmentak, orokorrak eta administratiboak
|
1,595.00 | 1,409.70 | 1,359.10 | 1,376.00 | 1,149.50 | 1,046.50 | 1,106.00 | 1,260.30 | 1,223.50 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
4,949.00 | 4,654.00 | 4,922.90 | 6,070.40 | 5,146.30 | 4,019.80 | 2,750.60 | 3,011.10 | 4,383.60 |
|
Ez-ustiapeneko diru-sarrerak
|
-30.90 | -13.00 | 9.70 | 3.60 | 8.30 | -3.80 | -9.70 | -11.20 | -16.90 |
|
Interesen diru-sarrerak
|
5.90 | 4.30 | 7.00 | 2.90 | 2.10 | 3.30 | 8.50 | - | - |
|
Interesen gastuak
|
- | - | 14.20 | 9.60 | 12.50 | 13.60 | 16.60 | 12.50 | 17.40 |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
-3.00 | -0.70 | 0.10 | 10.30 | 18.70 | 6.50 | -1.60 | 1.30 | 0.50 |
|
Zerga aurreko irabazia
|
138.00 | 152.20 | 306.10 | 604.00 | 542.00 | 282.90 | 198.10 | 364.60 | 263.40 |
|
Zerga-gastua
|
34.40 | 35.20 | 67.60 | 146.20 | 136.60 | 71.20 | 51.10 | 95.70 | -126.50 |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | - | - | - | - | - | - |
|
Irabazi garbia
|
103.60 | 117.00 | 238.50 | 457.80 | 405.40 | 211.70 | 147.00 | 268.90 | 389.90 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - |
|
EBITDA
|
5,399.00 | 5,067.70 | 5,305.40 | 6,420.40 | 5,442.50 | 4,310.30 | 3,043.50 | 3,302.40 | 4,662.60 |
|
Akzioko irabazia (oinarrizkoa)
|
0.59 | 0.67 | 1.35 | 2.57 | 2.28 | 1.19 | 0.83 | 1.52 | 2.28 |
|
EPS diluitua
|
0.59 | 0.66 | 1.34 | 2.56 | 2.28 | 1.19 | 0.83 | 1.52 | 2.28 |
|
Akzioen batez besteko haztatua
|
175.20 | 175.50 | 177.30 | 177.90 | 177.60 | 177.30 | 177.10 | 177.00 | 171.10 |
|
Akzioen batez besteko haztatu diluitua
|
175.90 | 176.10 | 178.20 | 178.80 | 178.10 | 177.60 | 177.30 | 177.20 | 171.30 |
|
Irabazi globala
|
105.50 | 116.60 | 240.10 | 452.80 | 404.60 | 212.40 | 148.10 | 268.30 | 389.00 |